KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Gains from Investment Securities (2016 - 2025)

Sarepta Therapeutics has reported Gains from Investment Securities over the past 16 years, most recently at -$36.9 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 200.38% year-over-year to -$36.9 million; the TTM value through Dec 2025 reached -$5.0 million, down 115.62%, while the annual FY2025 figure was $488192.0, 94.51% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$36.9 million at Sarepta Therapeutics, down from $3.5 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $36.8 million in Q4 2024 and troughed at -$36.9 million in Q4 2025.
  • A 5-year average of -$323489.9 and a median of $339000.0 in 2022 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: surged 816983.33% in 2022 and later crashed 566.09% in 2024.
  • Year by year, Gains from Investment Securities stood at -$13.7 million in 2021, then skyrocketed by 102.48% to $339000.0 in 2022, then rose by 5.31% to $357000.0 in 2023, then surged by 10205.6% to $36.8 million in 2024, then crashed by 200.38% to -$36.9 million in 2025.
  • Business Quant data shows Gains from Investment Securities for SRPT at -$36.9 million in Q4 2025, $3.5 million in Q3 2025, and $1.8 million in Q2 2025.